The approval of Yesafili marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the US.
from NDTV Profit https://ift.tt/5XDWsl2
from NDTV Profit https://ift.tt/5XDWsl2
Biocon Arm Gets US Regulator Nod For New Drug To Treat Eye Disorders
Reviewed by aamira sultan
on
May 21, 2024
Rating:
No comments: